Suppr超能文献

立陶宛肝硬化患者特定疾病的健康相关生活质量及其决定因素。

Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.

作者信息

Sumskiene Jolanta, Sumskas Linas, Petrauskas Dalius, Kupcinskas Limas

机构信息

Department of Gastroenterology, Kaunas University of Medicine, A.Mickeviciaus street 9, Kaunas LT-44307, Lithuania.

出版信息

World J Gastroenterol. 2006 Dec 28;12(48):7792-7. doi: 10.3748/wjg.v12.i48.7792.

Abstract

AIM

To evaluate disease-specific quality of life (QOL) in liver cirrhosis patients and to compare it with those of a healthy population. Also an important objective was to assess whether QOL in liver cirrhosis patients differs by age and gender, by type and severity of disease.

METHODS

The case group of 131 liver cirrhosis patients was selected. The control group of 262 was enrolled from a healthy population according to the scheme of case-control study. Clinical, demographic, laboratory data were collected. QOL was measured with a specific chronic liver disease questionnaire (CLDQ), which was translated and validated in Lithuanian. QOL scores were compared between groups by age, gender, type and severity of disease. Cronbach's alpha statistics calculation was used for evaluation of internal consistency reliability. Student's t test or ANOVA were used for evaluation hypothesis about probability equation.

RESULTS

QOL was significantly lower in liver cirrhosis patients than in healthy population (59.5 +/- 18.3 vs 85.3 +/- 12.3, P < 0.001). The significant QOL differences between case and control groups were observed in domains of worry and abdominal symptoms, the smaller differences-in emotional functions and systematic symptom domains. Significantly worse QOL was in observed patients with increased clinical severity of the disease measured by Child-Pugh class. Age, gender and etiology of disease had an insignificant effect on QOL in cirrhotic patients.

CONCLUSION

QOL was significantly impaired in all CLDQ domains in liver cirrhosis patients. Increase in severity of disease was the major factor associated with poorer QOL.

摘要

目的

评估肝硬化患者特定疾病的生活质量(QOL),并与健康人群的生活质量进行比较。另一个重要目标是评估肝硬化患者的生活质量是否因年龄、性别、疾病类型和严重程度而异。

方法

选取131例肝硬化患者作为病例组。根据病例对照研究方案,从健康人群中招募262例作为对照组。收集临床、人口统计学和实验室数据。使用一份特定的慢性肝病问卷(CLDQ)测量生活质量,该问卷已被翻译成立陶宛语并经过验证。按年龄、性别、疾病类型和严重程度比较两组的生活质量得分。使用Cronbach's alpha统计计算评估内部一致性可靠性。使用学生t检验或方差分析评估关于概率方程的假设。

结果

肝硬化患者的生活质量显著低于健康人群(59.5±18.3 vs 85.3±12.3,P<0.001)。病例组和对照组在担忧和腹部症状领域存在显著的生活质量差异,在情感功能和系统症状领域差异较小。根据Child-Pugh分级,疾病临床严重程度增加的患者生活质量明显更差。年龄、性别和疾病病因对肝硬化患者的生活质量影响不显著。

结论

肝硬化患者在所有CLDQ领域的生活质量均显著受损。疾病严重程度增加是生活质量较差的主要相关因素。

相似文献

1
Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.
World J Gastroenterol. 2006 Dec 28;12(48):7792-7. doi: 10.3748/wjg.v12.i48.7792.
2
[Psychometrics of the chronic liver disease questionnaire for patients with posthepatitic B cirrhosis].
Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):621-7. doi: 10.3760/cma.j.issn.1007-3418.2012.08.016.
3
Chronic liver disease questionnaire: translation and validation in Thais.
World J Gastroenterol. 2004 Jul 1;10(13):1954-7. doi: 10.3748/wjg.v10.i13.1954.
4
Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress.
Eur J Gastroenterol Hepatol. 2009 Apr;21(4):370-5. doi: 10.1097/MEG.0b013e328318ed19.
5
Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy.
World J Gastroenterol. 2007 Jun 7;13(21):3003-8. doi: 10.3748/wjg.v13.i21.3003.
6
Validation of the chronic liver disease questionnaire in Serbian patients.
World J Gastroenterol. 2013 Aug 14;19(30):4950-7. doi: 10.3748/wjg.v19.i30.4950.
10
Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey.
Int J Nurs Stud. 2006 Nov;43(8):1047-56. doi: 10.1016/j.ijnurstu.2005.11.012. Epub 2006 Sep 6.

引用本文的文献

1
Health-related Quality of Life in Patients With Liver Cirrhosis: A Randomized Study.
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101433. doi: 10.1016/j.jceh.2024.101433. Epub 2024 Apr 30.
2
Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life.
Saudi Pharm J. 2023 Aug;31(8):101668. doi: 10.1016/j.jsps.2023.06.001. Epub 2023 Jun 9.
3
Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.
JHEP Rep. 2021 Sep 28;3(6):100370. doi: 10.1016/j.jhepr.2021.100370. eCollection 2021 Dec.
4
The Assessment of the Quality of Life in Children with Chronic Liver Disease.
Turk J Gastroenterol. 2021 Sep;32(9):774-781. doi: 10.5152/tjg.2021.20594.
5
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis.
JHEP Rep. 2020 Mar 6;2(3):100099. doi: 10.1016/j.jhepr.2020.100099. eCollection 2020 Jun.
6
Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.
Palliat Med. 2019 Jan;33(1):24-36. doi: 10.1177/0269216318807051. Epub 2018 Oct 22.
7
Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis.
World J Gastroenterol. 2017 Oct 28;23(40):7321-7331. doi: 10.3748/wjg.v23.i40.7321.
8
Assessment of health-related quality of life and related factors in patients with chronic liver disease.
Braz J Infect Dis. 2015 Nov-Dec;19(6):590-5. doi: 10.1016/j.bjid.2015.08.003. Epub 2015 Sep 9.
9
Validation of the chronic liver disease questionnaire in Serbian patients.
World J Gastroenterol. 2013 Aug 14;19(30):4950-7. doi: 10.3748/wjg.v19.i30.4950.
10
Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients.
World J Gastroenterol. 2013 Jun 14;19(22):3494-501. doi: 10.3748/wjg.v19.i22.3494.

本文引用的文献

1
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.
BMC Gastroenterol. 2005 Jul 10;5:23. doi: 10.1186/1471-230X-5-23.
2
Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center.
Health Qual Life Outcomes. 2005 May 18;3:35. doi: 10.1186/1477-7525-3-35.
4
Chronic liver disease questionnaire: translation and validation in Thais.
World J Gastroenterol. 2004 Jul 1;10(13):1954-7. doi: 10.3748/wjg.v10.i13.1954.
5
Validation of the German version of the Chronic Liver Disease Questionnaire.
Eur J Gastroenterol Hepatol. 2004 Jun;16(6):599-606. doi: 10.1097/00042737-200406000-00014.
6
Determinants of health-related quality of life in patients with chronic liver diseases.
Clin Gastroenterol Hepatol. 2004 Feb;2(2):157-63. doi: 10.1016/s1542-3565(03)00315-x.
9
Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.
Dig Dis Sci. 2003 Aug;48(8):1622-6. doi: 10.1023/a:1024784327783.
10
Health-related quality of life in chronic liver disease: the impact of type and severity of disease.
Am J Gastroenterol. 2001 Jul;96(7):2199-205. doi: 10.1111/j.1572-0241.2001.03956.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验